On January 26, 2022, Chinook Therapeutics, Inc. accepted Alan Glicklich's resignation as Chief Medical Officer effective February 11, 2022 (the Resignation Date).
Chinook Therapeutics, Inc.
Equities
KDNY
US16961L1061
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+19.33% | 125B | |
+13.95% | 108B | |
-3.53% | 24.57B | |
+2.71% | 22.82B | |
-9.95% | 18.19B | |
-41.48% | 16.54B | |
-12.62% | 16.5B | |
+0.99% | 13.39B | |
+21.79% | 11.1B |